GL261 Cells
USD$450.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The GL261 cell line is a murine glioma model derived from C57BL/6 mice. This cell line is widely used in neuro-oncology research due to its ability to closely mimic the aggressive and invasive characteristics of human glioblastoma multiforme (GBM). GL261 cells grow as adherent cultures and form tumors when injected intracranially into syngeneic hosts, making them an ideal model for studying glioma progression, tumor microenvironment interactions, and therapeutic responses in an immunocompetent setting. GL261 cells are known for their high proliferative capacity and expression of various glioma-associated markers, such as glial fibrillary acidic protein (GFAP) and S100. They exhibit mutations in key oncogenes and tumor suppressor genes, including p53 and PTEN, which are commonly altered in human GBM. This genetic profile, along with their robust in vivo tumorigenicity, has made GL261 a valuable tool for preclinical evaluation of anti-glioma therapies, including chemotherapy, radiotherapy, and immunotherapy approaches. Researchers also utilize GL261 cells to investigate the mechanisms of glioma invasion and resistance to treatment, contributing to the development of more effective clinical strategies. |
|---|---|
| Organism | Mouse |
| Tissue | Brain |
| Disease | Glioblastoma |
| Synonyms | Glioma 261, GLIOMA 261, Glioma-261, GL-261 |
Characteristics
| Breed/Subspecies | C57BL/6 |
|---|---|
| Growth properties | Adherent |
Regulatory Data
| Citation | GL261 (Cytion catalog number 305225) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_Y003 |
Biomolecular Data
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305225-040725 | Certificate of Analysis | 18. Aug. 2025 | 305225 |
| 305225-240624 | Certificate of Analysis | 23. May. 2025 | 305225 |